Remimazolam Protects Against LPS-Induced Endotoxicity Improving Survival of Endotoxemia Mice.
Remimazolam Protects Against LPS-Induced Endotoxicity Improving Survival of Endotoxemia Mice.
复制标题
瑞马唑仑可预防脂多糖诱导的内毒素,提高内毒素血症小鼠的存活率
DOI:
10.3389/fphar.2021.739603
复制
发表时间:
2021
影响因子:
5.6
通讯作者:
Tang J
中科院分区:
文献类型:
--
作者:
Liu X;Lin S;Zhong Y;Shen J;Zhang X;Luo S;Huang L;Zhang L;Zhou S;Tang J
Remimazolam is a new benzodiazepine of sedative drugs with an ultra-short-acting anesthetic effect, commonly used for critically ill patients (especially septic patients) in intensive care units (ICUs). Although some anesthetics have been reported to show certain anti-inflammatory effects, the role of remimazolam in inflammation is still remained unknown. Here, we studied the effects of remimazolam on macrophage in response to LPS both in vivo and in vitro. Interestingly, compared with LPS treatment group, remimazolam remarkably improved survival rate of endotoxemia mice and decreased the release of LPS-induced inflammatory mediators (such as TNF-α, IL-6, and IL-1β). We further found that remimazolam not only inhibited the activation of MAPK signal pathway at 15 min after LPS treatment but also disturbed Rab5a related TLR4 expression at cell surface in response to LPS at a later time. Such evidence suggests that remimazolam might be beneficial to septic patients who are suffering from uncontrolled inflammatory responses.
登录
查看更多内容
影响因子:
2.9
作者:
Li, Fei;Liu, Jian;Liu, Nan;Kuhn, Leslie A.;Garavito, R. Michael;Ferguson-Millert, Shelagh
通讯作者:
Ferguson-Millert, Shelagh
影响因子:
5.2
作者:
Ramachandran G
通讯作者:
Ramachandran G
影响因子:
4.8
作者:
Chen, Yen-Jen;Hsieh, Ming-Yu;Leu, Tzeng-Horng
通讯作者:
Leu, Tzeng-Horng
影响因子:
8.8
作者:
Kilpatrick, Gavin J.;McIntyre, Margaret S.;Tilbrook, Gary S.
通讯作者:
Tilbrook, Gary S.
影响因子:
13.5
作者:
Guilarte TR
通讯作者:
Guilarte TR